Batch record
Tirzepatide · 60mg
Certificate information for lot TZ81726.
This record is incomplete. Fields the source document does not state are omitted. They are not passes.

Lot / batchTZ81726Accession74798
Certificate record
- Presentation
- 60mg
- Laboratory
- Mistral Diagnostics
- Reported
- August 23, 2026
- Accession
- 74798
- Lot / batch
- TZ81726
- Coverage
- This is the 60mg presentation certificate. Do not read these figures onto the 30mg variant.
- Products
- glp-tirz
- Compounds
- tirzepatide
- Labeled fill
- 60 mg
- Assayed net content
- 61.50 mg
Reported and unreported tests
- HPLC purity
- 99.67% · HPLC
- Net content
- 61.50 mg
The original laboratory report is the source for the results it states.
Match the record
1. Confirm the compound and presentation
Match Tirzepatide and the 60mg presentation.
2. Check the lot
Compare the batch identifier on the vial with TZ81726.
3. Read the original report
Review the laboratory, methods, dates and results in the source certificate. A missing line is not a pass.
Sources
For laboratory research only. Not for human or veterinary use. A result on this page does not establish suitability for administration.